You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR AMPHOTEC

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for AMPHOTEC

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00885703 ↗	High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1/Phase 2	2010-04-16	Cryptococcal meningitis (CM) is an infection of the membranes covering the brain and spinal cord, caused by the fungus Cryptococcus neoformans. CM most often affects people with compromised immune systems, like those with advanced HIV infection. This study explored the safety, tolerability, and therapeutic effect of a new treatment regimen with high-dose fluconazole for management of CM in HIV-infected patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for AMPHOTEC

Condition Name

Chart
Table

Condition Name for AMPHOTEC
Intervention	Trials
Cryptococcal Meningitis	1
HIV Infections	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for AMPHOTEC
Intervention	Trials
Meningitis, Cryptococcal	1
Meningitis	1
HIV Infections	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for AMPHOTEC

Trials by Country

Map
Table

Trials by Country for AMPHOTEC
Location	Trials
Kenya	2
South Africa	2
Uganda	1
Thailand	1
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for AMPHOTEC
Location	Trials
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for AMPHOTEC

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for AMPHOTEC
Clinical Trial Phase	Trials
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for AMPHOTEC
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for AMPHOTEC

Sponsor Name

Chart
Table

Sponsor Name for AMPHOTEC
Sponsor	Trials
National Institute of Allergy and Infectious Diseases (NIAID)	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for AMPHOTEC
Sponsor	Trials
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.